Ovensa

About:

Ovensa provides nanomedicine delivery platform with mucosal and brain-barrier crossing properties to generate advanced nanotherapeutics,

Website: https://ovensa.com/

Twitter/X: ovensa_inc

Top Investors: Anges Quebec, AQC Capital, Aligo Innovation

Description:

Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.

Total Funding Amount:

$1.91M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aurora, Ontario, Canada

Founded Date:

2012-01-01

Founders:

Philippe Tremblay, Stephane Gagne

Number of Employees:

1-10

Last Funding Date:

2017-09-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai